Araceli B. Reyes, MD
Dr Reyes is certified by the American Board of Pathology in Anatomic and Clinical Pathology and Cytopathology. She has been the Medical Director of the Northeast Division of Labcorp since 2012. She received her Medical degree from the University of Santo Thomas, Manila, Philippines, where she also completed a Clinical Pathology Residency. She completed residency training in Anatomic and Clinical Pathology as well as a Clinical Medicine/Immunopathology fellowship at the Bronx Lebanon Hospital/Albert Einstein College of Medicine, Bronx, New York.
Anjen Chenn, MD, PhD
Dr Chenn is board certified in clinical pathology and molecular genetic pathology. Dr Chenn received his undergraduate degree in biochemical sciences at Harvard University and his MD and PhD in neurosciences from Stanford University. He completed his residency in clinical pathology at the Brigham and Women's Hospital in Boston, Massachusetts, and post-doctoral training in the lab of Dr Christopher Walsh at Beth Israel Deaconess Medical Center in Boston, and was an instructor at Harvard Medical School.
Andrea Throop, PhD
Dr Throop is discipline director for routine chemistry at Labcorp and the technical director in the Phoenix Regional Laboratory. She has been with Labcorp since February 2016. Prior to joining Labcorp, Dr Throop served as a Production Manager at the Biodesign Center for Personalized Diagnostics overseeing a high-throughput molecular coloning and array facility. In addition she also served as a Quality Specialist and Technician for a COLA accredited in-practice laboratory.
Labcorp to Announce Second Quarter Financial Results on July 25, 2019
André Valcour, PhD, MBA, DABCC
Dr. Valcour serves as either national discipline director of the following Labcorp clinical specialties: endocrinology, allergy, hemostasis/thrombosis and automated immunoassay.
Alicia Carter, MD
Dr Carter is board certified in anatomic and clinical pathology and cytopathology. She earned her medical degree at the University of North Carolina at Chapel Hill, where she also completed her residency and fellowship training.
During her tenure at Labcorp, she has participated in the Scientific Management and Strategic Committee and several Business Advisory Teams, where she has been involved in reviewing the competitive and breakthrough strategies and planning for cytology and women’s health issues.